Compare COUR & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COUR | OLMA |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 932.9M | 863.0M |
| IPO Year | 2021 | 2020 |
| Metric | COUR | OLMA |
|---|---|---|
| Price | $5.80 | $11.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 10 |
| Target Price | $10.53 | ★ $44.89 |
| AVG Volume (30 Days) | ★ 7.5M | 1.7M |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.22 | 15.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $757,500,000.00 | N/A |
| Revenue This Year | $9.43 | N/A |
| Revenue Next Year | $6.40 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 9.04 | N/A |
| 52 Week Low | $5.00 | $4.12 |
| 52 Week High | $13.56 | $36.26 |
| Indicator | COUR | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 56.65 | 49.34 |
| Support Level | $5.48 | $7.79 |
| Resistance Level | $5.89 | $11.54 |
| Average True Range (ATR) | 0.27 | 0.72 |
| MACD | 0.07 | 0.33 |
| Stochastic Oscillator | 61.18 | 79.93 |
Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through two reporting segments: Consumer and Enterprise. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.